AI Tools
Stock Selection
Market Trend
Education
Pricing
My Trading Room
Beta
Back to 7891.TW Analysis
Revenue by Segments
EPS
EPS Diluted
Revenue
Operation Income
Net Income
Operating Expenses
Cash Flow
Cash & Debt
Current Contract Liabilities
7891 Cash Flow
Quarterly
TTM by Quarter
Annually
Financial
Valuation
Growth
Profitability
7891
博研醫藥
22.90
D
-5.02%
(-0.05)